Journey Medical Revenue and Competitors

Phoenix, AZ USA

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Journey Medical's estimated annual revenue is currently $29.1M per year.(i)
  • Journey Medical's estimated revenue per employee is $201,000

Employee Data

  • Journey Medical has 145 Employees.(i)
  • Journey Medical grew their employee count by 48% last year.

Journey Medical's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$22.3M1118%N/AN/A
#2
$17.7M88-19%N/AN/A
#3
$6.6M33-8%N/AN/A
#4
$29.1M14548%N/AN/A
#5
$1.2M6-50%N/AN/A
#6
$2.2M1110%N/AN/A
#7
$4.8M24-17%N/AN/A
#8
$34.8M1735%N/AN/A
#9
$46.2M2305%N/AN/A
#10
$3.2M16-11%N/AN/A
Add Company

What Is Journey Medical?

Journey Medical Corporation (Journey) is an innovative company focused on developing, acquiring, licensing, and commercializing branded dermatology products.\n\nJourney’s team is comprised of industry experts with decades of experience commercializing some of the most successful dermatology products in the prescription pharmaceutical industry. Journey is a subsidiary of Fortress Biotech, Inc.

keywords:N/A

N/A

Total Funding

145

Number of Employees

$29.1M

Revenue (est)

48%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Journey Medical News

2022-04-20 - Innovative class assignment developed for virtual education at ...

The Wayne State University School of Medicine Class of 2024 started its medical education journey solely online, inspiring an innovative...

2022-04-17 - Geisinger's journey to greatly expanded telehealth

Improving the quality of healthcare while lowering costs and increasing access in rural Pennsylvania counties is challenging, she said.

2022-04-06 - Journey Medical Corp Announces New Journey with the Experts ...

Dr. Fabbro sits down with Journey Medical to discuss cutaneous T-cell lymphoma, including what it is, why it occurs and how those affected can...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$40.5M1459%N/A
#2
$27.9M1467%N/A
#3
$46.9M147-2%N/A
#4
$46.9M147-12%N/A
#5
$23.9M15039%N/A